Company / Gross Profit
ARDELYX, INC. Gross Profit History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$4.7M
FY2019
5-year range
-
FY2017-FY2019
Trend
+118.6%
vs FY2018
Sector context
#30 of 29
Health Care
What the data says
Among 29 Health Care companies, ARDELYX, INC. is in the bottom -3% for gross profit. Declined from $24M to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2019.
Declined from $24M to $5M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -3% in Health CareTop 103% of 29This company $4.7M Sector average $3.5B
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2019, gross profit increased 118.6% year-over-year.
- Ranks #30 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $4.7M | +118.6% |
| FY2018 | $2.1M | -91.1% |
| FY2017 | $24.0M | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jul 2, 2026